$FXY
Invesco CurrencyShares Japanese Yen Trust

2023 Q1 Form 10-K Financial Statement

#000156459023002371 Filed on February 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $338.6K $1.053M
YoY Change 26.02% -9.46%
Operating Profit
YoY Change
Interest Expense $114.0K $354.5K
YoY Change 25.95% -9.45%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$338.6K -$1.053M
YoY Change 26.02% -9.46%
Net Earnings / Revenue
Basic Earnings Per Share -$0.10 -$0.43
Diluted Earnings Per Share -$0.10 -$0.43
COMMON SHARES
Basic Shares Outstanding 3.600M 2.463M
Diluted Shares Outstanding 3.258M 2.463M

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $220.6M $187.5M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $220.6M $187.5M
YoY Change 9.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $113.9K $96.66K
YoY Change 6.35%
SHAREHOLDERS EQUITY
Retained Earnings $0.00 $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $220.6M $187.5M
YoY Change 9.47%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$338.6K -$1.053M
YoY Change 26.02% -9.46%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$321.4K -$1.047M
YoY Change 18.79% -12.71%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 36.14M 39.96M
YoY Change 125.09% -176.91%
NET CHANGE
Cash From Operating Activities -321.4K -1.047M
Cash From Investing Activities
Cash From Financing Activities 36.14M 39.96M
Net Change In Cash 33.13M 16.22M
YoY Change 415.22% -121.39%
FREE CASH FLOW
Cash From Operating Activities -$321.4K -$1.047M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Trading Symbol
TradingSymbol
FXY
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1199760
CY2021 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
63758649
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
115719701
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-51961052
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22648204
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247053789
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187461552
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171244773
CY2021 us-gaap Interest Paid Net
InterestPaidNet
403863
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
144837000
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
187461552
CY2021Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
171244773
CY2021Q4 us-gaap Assets
Assets
171244773
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
60306
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2650000
CY2021Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2100000
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2100000
CY2021Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
171153887
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
171244773
CY2022 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2021 us-gaap Revenues
Revenues
0
CY2022 us-gaap Operating Expenses
OperatingExpenses
1053063
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1163058
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3600000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
187364894
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
187461552
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2022 us-gaap Revenues
Revenues
0
CY2021 us-gaap Sponsor Fees
SponsorFees
771622
CY2022 us-gaap Interest Expense
InterestExpense
354458
CY2021 us-gaap Interest Expense
InterestExpense
391436
CY2021 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
130201824
CY2021Q4 us-gaap Cash
Cash
19719691884
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
119547237
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Entity Registrant Name
EntityRegistrantName
Invesco CurrencyShares Japanese Yen Trust
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001353613
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2022 fxy Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-33298
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-6416176
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2022 dei City Area Code
CityAreaCode
800
CY2022 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2022 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 us-gaap Assets
Assets
187461552
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
64135
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
32523
CY2021Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
30580
CY2022Q4 us-gaap Liabilities
Liabilities
96658
CY2021Q4 us-gaap Liabilities
Liabilities
90886
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2650000
CY2022 us-gaap Sponsor Fees
SponsorFees
698605
CY2021 us-gaap Operating Expenses
OperatingExpenses
1163058
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1053063
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.43
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.43
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.52
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.52
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2463014
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2463014
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2241096
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2241096
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1163058
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1053063
CY2022 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
1053063
CY2021 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
1163058
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1053063
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-1163058
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
3829
CY2021 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-24275
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1943
CY2021 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-12427
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1047291
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
159508534
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
39961297
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-22697227
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
16216779
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-75809016
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171244773
CY2022 us-gaap Interest Paid Net
InterestPaidNet
352515
CY2022 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2007-02-01
CY2022Q4 fxy Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
10000
CY2021 fxy Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
CY2021 fxy Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">B.  Accounting Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</p>
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 fxy Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2022Q4 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0020
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
21053881528
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
15902847088
CY2022 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
136111791
CY2022Q4 us-gaap Cash
Cash
24734614533
CY2022Q4 us-gaap Cash
Cash
187461552
CY2021 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
7056729586
CY2021 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
12713904335
CY2021Q4 us-gaap Cash
Cash
171244773

Files In Submission

Name View Source Status
0001564590-23-002371-index-headers.html Edgar Link pending
0001564590-23-002371-index.html Edgar Link pending
0001564590-23-002371.txt Edgar Link pending
0001564590-23-002371-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fxy-10k_20221231.htm Edgar Link pending
fxy-20221231.xsd Edgar Link pending
fxy-ex231_8.htm Edgar Link pending
fxy-ex311_9.htm Edgar Link pending
fxy-ex312_6.htm Edgar Link pending
fxy-ex321_7.htm Edgar Link pending
fxy-ex322_10.htm Edgar Link pending
g3k0yfgm3fhz000001.jpg Edgar Link pending
g3k0yfgm3fhz000002.jpg Edgar Link pending
g3k0yfgm3fhz000003.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R3.htm Edgar Link pending
fxy-20221231_lab.xml Edgar Link unprocessable
fxy-20221231_pre.xml Edgar Link unprocessable
fxy-10k_20221231_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
fxy-20221231_def.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
fxy-20221231_cal.xml Edgar Link unprocessable